Treatment of narcolepsy with methamphetamine

Area of Science:

• Neuroscience
• Pharmacology
• Sleep Medicine

Background:

• Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness.
• Current treatments for narcolepsy often have limitations and side effects.
• Stimulant medications are sometimes used off-label to manage narcolepsy symptoms.

Purpose of the Study:

• To investigate the dose-dependent effects of methamphetamine on daytime sleep tendency and performance in individuals with narcolepsy and healthy controls.
• To compare the efficacy of methamphetamine in narcoleptic versus control subjects.
• To assess the safety and side effects of methamphetamine in this context.

Main Methods:

• A double-blind, randomized, placebo-controlled study involving eight pairs of narcoleptic and matched control subjects.
• Four treatment conditions: baseline, placebo, low-dose, and high-dose methamphetamine.
• Assessment of daytime sleep tendency using the Multiple Sleep Latency Test (MSLT) and performance using a driving task.
• Nighttime polysomnography to evaluate sleep architecture.

Main Results:

• Methamphetamine dose-dependently decreased sleep latency on the MSLT in both narcoleptics and controls.
• Narcoleptics showed significant improvements in driving task performance with methamphetamine, with high doses normalizing function.
• Methamphetamine affected sleep continuity and REM sleep, with effects being dose-dependent. Elimination half-life was 15.9–22.0 hours.
• Mild, dose-dependent side effects, primarily CNS and GI, were observed.

Conclusions:

• Methamphetamine effectively reduces daytime sleepiness and enhances performance in both narcolepsy patients and healthy individuals.
• High doses of methamphetamine can restore functional performance in narcoleptics to levels comparable to unmedicated controls.
• Methamphetamine demonstrates a dose-dependent efficacy and safety profile for managing symptoms of excessive daytime sleepiness.